Log In
Print this Print this

navarixin (MK-7123, SCH 527123) (formerly PS291822)

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionCXC chemokine receptor 2 (CXCR2) antagonist
Molecular Target CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionCXC chemokine receptor 2 (CXCR2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today